Smead Capital Management disclosed 23 US equity positions worth $135.8m in its Q2 2008 13F filing. Its largest position is MSFT at 13.2% of the reported book, followed by Merck & Co Inc and Accenture Ltd. Versus Q1 2008 it opened 4 new positions, added to 7, reduced 10 and exited 7.
$136m
Reported equity book
Sum of the long US equity positions in the filing, at the values filed. Options are excluded.
23
Positions
Distinct securities in the equity book with a reported value above zero. Options are excluded.
13.2%
Largest position
The largest single position as a share of the reported equity book.
75.7%
Top 10 weight
The ten largest positions together, as a share of the reported equity book.
14
Effective positions
1 / HHI of portfolio weights: the number of equal-weight positions the book behaves like.
75
Quarters on file since Q4 2007
Quarters for which this manager's 13F holdings are on record.